Blog News | Page 2 | Atlantia Food Clinical Trials

FDA June Announcements: New Qualified Health Claims and treatments approved

FDA has announced recent approvals in June. We would like to highlight the approval granted to EPA and DHA Omega-3 supplements as well as to a treatment for paediatric patients.  The Victoza (liraglutide) injection is a form of treatment for paediatric patients who are 10 years and older and who are diagnosed with type 2 diabetes. Type 2 diabetes is the most common form of diabetes, occurring when the pancreas cannot make enough insulin to keep blood sugar at normal levels.


World Microbiome Day 2019

World Microbiome Day is an annual event that is about creating awareness around the world of microbes.  This annual event was launched last year by the APC Microbiome Ireland, a national institute with which Atlantia is delighted to be close partners with. The theme of this years World Microbiome Day is ‘Bacterial Resistance to Antibiotics’.


Clinical implications of microbiome skin innovation products

The innovation race to release cosmetic innovations aiming the skin microbiome has sped up after recent research highlighting a possible relationship between gastrointestinal, skin, and mental and cognitive health, well known as the gut-brain-skin axis. What are the main clinical implications of the emergent trend?


Atlantia Food Clinical Trials Expands to the US

Washington D.C., March 13th, 2019. At an event in Washington DC, An Taoiseach, Leo Varadkar TD, today announced the opening of new offices for Cork-based Atlantia Food Clinical Trials in Chicago.  Atlantia Food Clinical Trials will create an initial six jobs on opening in Chicago, growing to 20 positions within two years.